In our T2D real-world patients treated with a low-premixed insulin preparation, the average time spent in hypoglycemia was 33.1 min daily (2.3%), with 11.5 min in level 2 hypoglycemia. This evidence concerns the gene INS and type 2 diabetes mellitus.